Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).
about
Gender analysis of moxifloxacin clinical trialsA focus on intra-abdominal infections.2013 WSES guidelines for management of intra-abdominal infections.Efficacy and safety of moxifloxacin in hospitalized patients with secondary peritonitis: pooled analysis of four randomized phase III trials.WSES consensus conference: Guidelines for first-line management of intra-abdominal infections.Delafloxacin: design, development and potential place in therapyUpdate on the cardiac safety of moxifloxacin.Clinical Benefit of Appropriate Empirical Fluoroquinolone Therapy for Adults with Community-Onset Bacteremia in Comparison with Third-Generation-Cephalosporin Therapy.Moxifloxacin monotherapy for treatment of complicated intra-abdominal infections: a meta-analysis of randomised controlled trials.Severe autogenously fecal peritonitis in Wistar rats with permanent bilateral carotid occlusion. Response to intra peritoneal moxifloxacin combined with dexamethasone.Clinical efficacy and correlation of clinical outcomes with in vitro susceptibility for anaerobic bacteria in patients with complicated intra-abdominal infections treated with moxifloxacin.Fluoroquinolones increase the risk of serious arrhythmias: A systematic review and meta-analysis.Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.
P2860
Q28538319-8FF0A346-1C23-4ABC-A761-F449A09E4F69Q33763449-F3896148-76AD-481E-8AC0-B765E2935E4DQ34321150-5423B300-D26B-43A6-9987-F3F5DC865529Q34330502-41688A75-C8DB-45C2-9A24-C5493FCC3F2CQ34541183-54C22BFA-9A17-4909-8BEC-7BC0E4924A9DQ34554381-4A59C0E4-AC8D-449A-AC2D-6848FFEC683BQ36345861-2CB53C68-B2FE-4424-93A1-57E0667C980AQ37612940-390D5612-CC5E-4AEB-9BCD-92512469D7ABQ37976854-C47FB8C1-8664-432A-B4F1-6947B2705B2BQ44778276-6960E7C6-87EF-4F3E-9D78-769CFA732524Q45074770-0FCF3E75-F644-445F-BA56-A55F21F5A49BQ45330989-E3B9A4FA-85B5-4749-9347-60415FB73BCBQ46770277-93D16CF9-799E-436E-829D-91B009B62F8B
P2860
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections (the AIDA Study).
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Moxifloxacin for the treatment ...... l infections (the AIDA Study).
@en
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections
@nl
type
label
Moxifloxacin for the treatment ...... l infections (the AIDA Study).
@en
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections
@nl
prefLabel
Moxifloxacin for the treatment ...... l infections (the AIDA Study).
@en
Moxifloxacin for the treatment of patients with complicated intra-abdominal infections
@nl
P2093
P2860
P1476
Moxifloxacin for the treatment ...... l infections (the AIDA Study).
@en
P2093
AIDA Study Group
E Muehlhofer
P Reimnitz
P2860
P304
P356
10.1179/JOC.2009.21.2.170
P577
2009-04-01T00:00:00Z